Filter
909
Filtered Results: 909
Text search:
medicine
manufacturing
Featured
Recommendations
78
New Publications
217
Language
Document type
No document type
407
Studies & Reports
203
Guidelines
147
Strategic & Response Plan
54
Manuals
50
Fact sheets
24
Situation Updates
9
Training Material
7
Resource Platforms
4
Brochures
2
Infographics
1
Videos
1
Countries / Regions
India
41
Kenya
35
Global
33
Nigeria
24
Uganda
23
Ethiopia
21
Ghana
20
Western and Central Europe
16
South Africa
16
Tanzania
15
Nepal
13
Africa
13
Zambia
13
Sierra Leone
12
Rwanda
12
Bangladesh
12
Lesotho
10
Philippines
10
South–East Asia Region
9
Malawi
8
West and Central Africa
8
East and Southern Africa
8
Liberia
8
Myanmar / Burma
8
Ukraine
7
Syria
7
Zimbabwe
7
Latin America and the Carribbean
7
Namibia
7
Botswana
7
Eastern Europe
5
Indonesia
5
Thailand
4
USA
4
Haiti
4
Cambodia
4
Congo, Democratic Republic of
4
Eswatini/ Swaziland
4
Cameroon
3
Albania
3
Asia
3
Moldova
3
Sri Lanka
3
Russia
3
South Sudan
3
Pakistan
3
Tajikistan
2
Benin
2
China
2
Laos
2
Senegal
2
Guinea
2
Mozambique
2
Middle East and North Africa
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Mauritius
2
United Kingdom
2
Sudan
2
Yemen
2
Serbia
1
Australia
1
Afghanistan
1
Mongolia
1
Jordan
1
Germany
1
Turkmenistan
1
Maldives
1
Bosnia and Herzegovina
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Brazil
1
Egypt
1
Angola
1
Chad
1
Iraq
1
Ecuador
1
Solomon Islands
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
342
Clinical Guidelines
72
Public Health
42
Pharmacy & Technologies
34
Key Resources
31
Women & Child Health
15
Capacity Building
6
Toolboxes
COVID-19
106
Pharmacy
93
AMR
91
HIV
58
Planetary Health
46
TB
36
Mental Health
30
NTDs
25
Rapid Response
23
Global Health Education
17
NCDs
16
Ebola & Marburg
14
Disability
13
Conflict
13
Specific Hazards
10
Caregiver
8
Natural Hazards
7
Health Financing Toolbox
7
Refugee
4
Cholera
3
Zika
1
Polio
1
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of CVD diseases. Affordable essential medicines and t...
The MSF qualification scheme is concerned with the pharmaceutical quality assessment for drugs. This procedure is applicable to products for international supply, i.e. products supplied through the MSF procurement centres. This qualification procedure is not applicable for local purchase, i.e. purch...
The safety of medicines in Zambia - why health workers need to take action | Produced by the National Pharmacovigilance Unit (NPVU)
First edition, November 1997 | Revised July 2002
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread.
We have reac...
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
An overview of COVID-19 Vaccine AstraZeneca and why it is authorised in the EU. Available in 22 languages
18 Febr. 2021
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment of people infecte...
Am. J. Trop. Med. Hyg., 106 (Suppl 5), 2022, pp. 56–60. Lymphatic filariasis (LF) is a parasitic disease that is a major cause of chronic disability in the developing world. According to the 2021–2030 road map for neglected tropical diseases (NTDs) published by the World Health Organization (WHO...
To understand the national situation, Ethiopia did a situation assessment, launched its first strategy in 2011, and took action to contain AMR, as detailed in the blue boxes found throughout this strategy. This updated version of the strategy was in response to the revised health and medicines polic...
The new review paper, The Impacts of Climate Change on Health, identifies the extent to which increasing emissions, extreme weather and temperatures elevate health risks, from infectious disease to malnutrition, and assesses the associated health burden. It concludes that the health burden will exce...
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resistance and lead to loss of confidence in health prof...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
